Back to Ovarian Cancer

NCT03883542

NCT03883542
Active, Not Recruiting Not Applicable

Who may be able to join

Who might be able to join this trial:

  • Preserved tumour tissue samples (stored in paraffin wax) from the original borderline ovarian tumour must be available and in good enough condition for DNA testing.
  • The original tissue slides from the tumour must be available for review by a central pathology team.

Who may not be able to join:

  • People who have been diagnosed with invasive ovarian cancer (a more advanced form of ovarian cancer that has grown into surrounding tissue).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Active, Not Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
clinicaltrials_gov
Start date
1 January 2017
Est. completion
31 December 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

genetic mutations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov